https://calrheum.org/access-to-biologics/ 2024-01-10T02:06:18+00:00 https://calrheum.org/wp-content/uploads/2024/01/biologics.jpg https://calrheum.org/limiting-step-therapy-policies-to-protect-patients/ 2024-01-10T03:27:01+00:00 https://calrheum.org/wp-content/uploads/2024/01/StepTherapyissuepage1050x300.jpg https://calrheum.org/covered-california-and-state-implementation-of-the-affordable-care-act/ 2024-01-10T03:37:55+00:00 https://calrheum.org/november-2023-legislative-update/ 2024-02-09T00:21:51+00:00 https://calrheum.org/rheumatologists-face-challenges-in-identifying-high-quality-covid-19-literature/ 2024-02-09T00:21:51+00:00 https://calrheum.org/what-happens-when-covid-19-collides-with-flu-season/ 2024-02-09T00:21:51+00:00 https://calrheum.org/wp-content/uploads/2024/01/pexels-anna-shvets-3902732.jpg https://calrheum.org/oxford-university-to-study-adalimumab-as-potential-covid-19-treatment/ 2024-02-09T00:21:51+00:00 https://calrheum.org/wp-content/uploads/2024/01/pexels-photo-3936369.jpg https://calrheum.org/anthems-specialty-pharmacy-mandate/ 2024-02-09T00:21:51+00:00 https://calrheum.org/cra-press-release-october-29-2020-re-anthem-spp-mandate/ 2024-02-09T00:21:51+00:00 https://calrheum.org/wp-content/uploads/2024/01/CRA-Press-Release_Anthem_10-29-2020_1-791x1024-1.jpg https://calrheum.org/wp-content/uploads/2024/01/CRA-Press-Release_Anthem_10-29-2020_2-791x1024-1.jpg https://calrheum.org/manuscript-with-oral-surveillance-data-available-in-the-new-england-journal-of-medicine-january-27-issue/ 2024-02-09T00:21:51+00:00 https://calrheum.org/cra-diamond-member-news-pfizer-medical-portal-open/ 2024-02-09T00:21:51+00:00 https://calrheum.org/wp-content/uploads/2024/01/PNG_Pfizer_Logo_Color_CMYK-300x124-1.png https://calrheum.org/cra-diamond-member-news-as-lessons-from-hcp-journeys/ 2024-02-09T00:21:51+00:00 https://calrheum.org/cra-diamond-member-news-abbvie-ankylosing-spondylitis-resource/ 2024-02-09T00:21:51+00:00 https://calrheum.org/cra-issues-letters-to-california-business-advocacy-organizations-warning-them-of-consequences-of-anthem-blue-cross-mandate/ 2024-02-09T00:21:51+00:00 https://calrheum.org/anthem-clarifies-specialty-pharmacy-mandate/ 2024-02-09T00:21:51+00:00 https://calrheum.org/u-s-fda-approves-cyltezo-adalimumab-adbm-as-first-interchangeable-biosimilar-with-humira/ 2024-02-09T00:21:51+00:00 https://calrheum.org/abbvie-receives-fda-approval-for-rinvoq-to-treat-active-psoriatic-arthritis/ 2024-02-09T00:21:51+00:00 https://calrheum.org/cra-president-dr-samy-metyas-featured-in-capitol-weekly-op-ed/ 2024-02-09T00:21:51+00:00 https://calrheum.org/rheumatology-screening-prevention-and-awareness/ 2024-02-09T00:21:51+00:00 https://calrheum.org/wp-content/uploads/2024/01/RSPAissue1050x300.jpg https://calrheum.org/medication-adherence/ 2024-02-09T00:21:51+00:00 https://calrheum.org/wp-content/uploads/2024/01/SADsissuepage1050x300.jpg https://calrheum.org/uniform-prior-authorization/ 2024-02-09T00:21:51+00:00 https://calrheum.org/wp-content/uploads/2024/01/Issues_Proactive_Admin-Simp_1050.jpg https://calrheum.org/cal-medi-connect/ 2024-02-09T00:21:51+00:00 https://calrheum.org/wp-content/uploads/2024/01/Cal-Medi-Connect.jpg https://calrheum.org/california-legislators-must-prioritize-patients-over-profits/ 2024-05-01T14:58:32+00:00 https://calrheum.org/cra-diamond-member-news-pfizer-study-recruitment/ 2024-05-30T18:56:05+00:00 https://calrheum.org/cra-platinum-member-news-continued-coverage-for-patients-with-ra/ 2024-10-02T21:03:29+00:00 https://calrheum.org/wp-content/uploads/2024/09/CRA-Blog-Post_Genentech_FINAL-IMAGE.png https://calrheum.org/cra-platinum-member-news-information-and-resources-for-patients-considering-an-autoinjector-to-manage-the-symptoms-of-rheumatoid-arthritis-ra/ 2024-10-08T19:42:17+00:00 https://calrheum.org/wp-content/uploads/2024/10/Screenshot-2024-10-08-at-8.39.30%E2%80%AFAM.png https://calrheum.org/wp-content/uploads/2024/10/Screenshot-2024-10-08-at-2.25.40%E2%80%AFPM.png